false000092661700009266172023-09-122023-09-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 12, 2023

Aspira Women’s Health Inc.

(Exact name of registrant as specified in its charter)





Delaware

001-34810

33-0595156

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)





12117 Bee Caves Road, Building III, Suite 100, Austin, Texas

78738

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (512) 519-0400



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)





☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))





☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Securities registered pursuant to Section 12(b) of the Act:





Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

AWH

Nasdaq Capital Market



Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).



Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




‎

Item 8.01 Other Events.

On September 12, 2023, Aspira Women’s Health Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) that the Company has regained compliance with the minimum Market Value of Listed Securities of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”), based on achieving a market value of at least $35 million from August 25, 2023 to September 11, 2023. The Notice also indicated that because the Company is now in compliance with the MVLS Requirement, Nasdaq considers the matter close.

As the Company previously reported on that certain Current Report on Form 8-K filed on July 14, 2023 with the U.S. Securities and Exchange Commission, on July 11, 2023, the Company received a deficiency letter from the Staff notifying the Company that, for the preceding 30 consecutive business days, the Company had not been in compliance with the MVLS Requirement.

There can be no assurance that the Company will be successful in maintaining its listing of its common stock on the Nasdaq Capital Market.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit  Description

No.

104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.









ASPIRA WOMEN’S HEALTH INC.



Date: September 13, 2023

By:

/s/ Torsten Hombeck



Torsten Hombeck



Chief Financial Officer





v3.23.2
Document and Entity Information
Sep. 12, 2023
Document And Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Sep. 12, 2023
Entity Registrant Name Aspira Women’s Health Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-34810
Entity Tax Identification Number 33-0595156
Entity Address, Address Line One 12117 Bee Caves Road
Entity Address, Address Line Two Building III
Entity Address, Address Line Three Suite 100
Entity Address, City or Town Austin
Entity Address, State or Province TX
Entity Address, Postal Zip Code 78738
City Area Code 512
Local Phone Number 519-0400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol AWH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000926617
Amendment Flag false
Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Aspira Womans Health Charts.
Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Aspira Womans Health Charts.